학술논문

Safety experience with extended exposure to ofatumumab in patients with relapsing multiple sclerosis from phase 2 and 3 clinical trials
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; DEC 2020, 26 3_SUPPL, p232-p233, 2p. Supplement: 3_
Subject
Language
English
ISSN
14770970